Literature DB >> 15242606

Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension.

Xiaoshan Min1, Byung-Hoon Lee, Melanie H Cobb, Elizabeth J Goldsmith.   

Abstract

WNK kinases comprise a small group of unique serine/threonine protein kinases that have been genetically linked to pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Here we present the structure of the kinase domain of WNK1 at 1.8 A resolution, solved in a low activity conformation. A lysine residue (Lys-233) is found in the active site emanating from strand beta2 rather than strand beta3 as in other protein kinases. The activation loop adopts a unique well-folded inactive conformation. The conformations of the P+1 specificity pocket, the placement of the conserved active site threonine (Thr-386), and the exterior placement of helix C, contribute to the low activity state. By homology modeling, we identified two hydrophobic residues in the substrate-binding groove that contribute to substrate specificity. The structure of the WNK1 catalytic domain, with its unique active site, may help in the design of therapeutic reagents for the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242606     DOI: 10.1016/j.str.2004.04.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  84 in total

Review 1.  PseudoGTPase domains in p190RhoGAP proteins: a mini-review.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

Review 3.  Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.

Authors:  Min Goo Lee; Ehud Ohana; Hyun Woo Park; Dongki Yang; Shmuel Muallem
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

4.  WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis.

Authors:  Jesse Rinehart; Kristopher T Kahle; Paola de Los Heros; Norma Vazquez; Patricia Meade; Frederick H Wilson; Steven C Hebert; Ignacio Gimenez; Gerardo Gamba; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

5.  WNK1 activates SGK1 to regulate the epithelial sodium channel.

Authors:  Bing-e Xu; Steve Stippec; Po-Yin Chu; Ahmed Lazrak; Xin-Ji Li; Byung-Hoon Lee; Jessie M English; Bernardo Ortega; Chou-Long Huang; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Crystal structure of domain-swapped STE20 OSR1 kinase domain.

Authors:  Seung-Jae Lee; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

7.  Protein AMPylation by an Evolutionarily Conserved Pseudokinase.

Authors:  Anju Sreelatha; Samantha S Yee; Victor A Lopez; Brenden C Park; Lisa N Kinch; Sylwia Pilch; Kelly A Servage; Junmei Zhang; Jenny Jiou; Monika Karasiewicz-Urbańska; Małgorzata Łobocka; Nick V Grishin; Kim Orth; Roza Kucharczyk; Krzysztof Pawłowski; Diana R Tomchick; Vincent S Tagliabracci
Journal:  Cell       Date:  2018-09-27       Impact factor: 41.582

Review 8.  Emerging Targets of Diuretic Therapy.

Authors:  C-J Cheng; A R Rodan; C-L Huang
Journal:  Clin Pharmacol Ther       Date:  2017-07-10       Impact factor: 6.875

9.  The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.

Authors:  Koichi Fukuda; Sudhiranjan Gupta; Ka Chen; Chuanyue Wu; Jun Qin
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

10.  Pseudokinases: functional insights gleaned from structure.

Authors:  Alexandr P Kornev; Susan S Taylor
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.